Advanced search
Publication Cover
Human Vaccines & Immunotherapeutics Volume 14, 2018 - Issue 2
Submit an article Journal homepage
2,193
Views
1
CrossRef citations to date
0
Altmetric
Research Paper

MF59-adjuvanted influenza vaccine (FLUAD®) elicits higher immune responses than a non-adjuvanted influenza vaccine (Fluzone®): A randomized, multicenter, Phase III pediatric trial in Mexico

Aurelio Cruz-ValdezCenter of Investigation of Public Health, National Institute of Public Health, Cuernavaca, Morelos, México
,
Gabriel Valdez-ZapataDepartment of Pediatric Investigation, UNAMIS, Mérida, Yucatán, México
,
Sanjay S. PatelInfluenza Vaccines Development, Novartis Influenza Vaccines, Cambridge, MA, USA
,
Flavia V. CastelliVaccines R&D, GSK, Bs.As., Argentina
,
Marcia G. GarciaVaccines R&D, GSK, Mexico City, México
,
Wim T. JansenDepartment of BioStatistics GSK, Amsterdam, The Netherlands
,
Ashwani Kumar AroraClinical Development, Novartis Vaccines, Siena, Italy
&
Esther HeijnenSeasonal Influenza Vaccines, Seqirus, Amsterdam, The NetherlandsCorrespondence[email protected]
 show all
Pages 386-395 | Received 16 May 2017, Accepted 25 Aug 2017, Published online: 03 Jan 2018

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

Order Reprints Request Permissions

For more information please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.